Anna Beck

Assistant Professor

University of Wisconsin-Madison

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anna Beck is an Assistant Professor at the University of Wisconsin–Madison, USA. Her research areas encompass cancer biology, with a particular focus on markers of recurrence in various cancers, including papillary thyroid cancer and breast cancer. She has contributed significantly to the understanding of cancer stem cell markers and their predictive value, as well as the impact of multidisciplinary tumor boards on treatment decision-making.

Articles (10)

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Tiandao Li

Washington University in St. Louis

UNITED STATES

View details

Anand Rajan KD

University of Iowa Hospitals and Clinics

UNITED STATES

View details

Ronald Weigel

Iowa State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Beck

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

ASO Visual Abstract: Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Varies in Males Versus Females With Papillary Thyroid Cancer

Risk of Recurrence and Cancer Stem Cell Marker CD133 Expression Vary in Males Versus Females with Papillary Thyroid Cancer

Does Non-Classic Lobular Carcinoma In Situ at the Lumpectomy Margin Increase Local Recurrence?

Axillary lymph node dissection: Dead or still alive?

AP-2α Regulates S-Phase and Is a Marker for Sensitivity to PI3K Inhibitor Buparlisib in Colon Cancer

A Pilot Study of Preoperative Vandetanib on Markers of Proliferation and Apoptosis in Breast Cancer.

Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.

Risk management recommendations and patient acceptance vary with high-risk breast lesions.

Influence of endocrine multidisciplinary tumor board on patient management and treatment decision making.

AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis

Collaborators (3)

Tiandao Li

Anand Rajan KD

Ronald Weigel

Make your next move.